The FDA has approved a new drug treatment for a type of brain cancer called low-grade glioma. The drug, called vorasidenib, is a targeted cancer… Read More »FDA Approves Drug Targeting Johns Hopkins-Discovered Brain Cancer Gene Mutation
In this Kimmel in DC podcast, Dr Ashwani Rajput talks with Dr Solmaz Sahebjam about the treatment of tumors in the brain and along the… Read More »Kimmel in DC with Dr. Ashwani Rajput – Neuro-Oncology
A new research study published June 20 in Neuropathology and Applied Neurobiology found key biological differences between aggressive and more indolent, less harmful brain tumors… Read More »Regulator of Neurofibromatosis Type 1-Caused Brain Tumors Uncovered
In the next On Target podcast, Dr Akila Viswanathan speaks with Dr Lawrence Kleinberg about the treatment of brain cancer and engaging the immune system… Read More »On Target with Dr. Akila Viswanathan – Brain Cancer
Our next podcast with Dr Bill Nelson is now available. Today, he speaks with neurologic oncologist Dr Byram Ozer about the multi-disciplinary approach to brain… Read More »Cancer Matters with Dr. Bill Nelson – Brain Cancer
Pictured: Nanoparticles releasing microRNAs inside a brain cancer cell. Johns Hopkins Kimmel Cancer Center brain cancer researchers announced that they successfully delivered ultra-tiny nano-size packets… Read More »Special Delivery Targets Brain Cancer Cells
A rare cell line developed by Johns Hopkins researchers is giving scientists their first chance in decades to test new therapies for a lethal pediatric… Read More »Two Studies Uncover Potential Treatments for Lethal Pediatric Brain Cancer DIPG
This isn't a new story, nor one that has a definitive answer. Public health and other experts are still trying to sort out any link between… Read More »Cell Phones and Cancer